Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines

Heather A. Lillemoe, Roberto N. Miranda, Loretta J. Nastoupil, Mark W. Clemens, Kelly K. Hunt

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon peripheral T cell lymphoma arising in response to textured-surface breast implants. Frequently, BIA-ALCL is indolent and typically presents with peri-implant swelling after breast reconstruction or cosmetic augmentation. However, patients can present with an invasive breast or chest wall mass, palpable lymphadenopathy, or metastatic disease. The current literature is limited regarding surgical recommendations for patients with a more aggressive presentation of BIA-ALCL. This report aims to review the various clinical manifestations of BIA-ALCL, including the more advanced and less frequently encountered presentations, with an emphasis on a multidisciplinary approach, with early involvement of a surgical oncologist.

Original languageEnglish (US)
Pages (from-to)5722-5729
Number of pages8
JournalAnnals of surgical oncology
Volume29
Issue number9
DOIs
StatePublished - Sep 2022

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines'. Together they form a unique fingerprint.

Cite this